1) Boku N, Yamamoto S, Fukuda H, et al : Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group : Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer : a randomised phase 3 study. Lancet Oncol 2009 ; 10 : 1063- 1069
3) Fuchs CS, Marshall J, Mitchell E, et al Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer : results from the BICC-C Study. J Clin Oncol 2007 ; 25 : 4779-4786
4) Falcone A, Ricci S, Brunetti I, et al : Gruppo Oncologico Nord Ovest : Phase M trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer : the Gruppo Oncologico Nord Ovest. J Clin Oncol 2007 ; 25 : 1670-1676
5) Hurwitz H, Fehrenbacher L, Novotny VV, et al Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N En 171 T MM 2004 ; 350 : 2335-2342